Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00132457 · ClinicalTrials.gov registry record · NA
Use of Self-collected Vaginal Swabs as an Innovative Approach to Facilitate Testing for Repeat Chlamydia Infection
A NA study, sponsored by Centers for Disease Control and Prevention.
- Completed
- Registry status
- NA
- Development phase
- 1,830
- Enrollment target
NCT00132457 is a NA study that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 1,830 participants.
The verdict
NCT00132457, a NA study, has completed, sponsored by Centers for Disease Control and Prevention.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,830 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if, among women who were treated for a prior chlamydial infection, home-based, self-collected vaginal swabs can increase rescreening for chlamydia in comparison with rescreening in the clinic. The study design is two randomized trials with enrollment at multiple family planning clinics and sexually transmitted disease (STD) clinics following a common protocol.
Interventions
- PROCEDURE Self-collected vaginal swab for chlamydia testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,830 participants |
| Start Date | 2003-10 |
| Est. Completion | 2008-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00132457
The ClinicalTrials.gov registry entry for NCT00132457 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,830 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Centers for Disease Control and Prevention, which has 139 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Self-collected vaginal swab for chlamydia testing is the first listed.
NCT00132457 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00132457 about?
NCT00132457 is a clinical study titled "Use of Self-collected Vaginal Swabs as an Innovative Approach to Facilitate Testing for Repeat Chlamydia Infection". The purpose of this study is to determine if, among women who were treated for a prior chlamydial infection, home-based, self-collected vaginal swabs can increase rescreening for chlamydia in comparison with rescreening in the clinic. The study design is two randomized trials with enrollment at mult...
What is the current status of trial NCT00132457?
This trial is currently completed. It is a NA study. The enrollment target is 1,830 participants. The study started on 2003-10. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00132457?
The interventions under investigation include: Self-collected vaginal swab for chlamydia testing (PROCEDURE).
Who is sponsoring clinical trial NCT00132457?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.